sábado, 20 de diciembre de 2025

Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion Authors: Joshua Brody, MD; Liz Brém, MD; Lorna Warwick

https://www.medscape.org/viewarticle/personalizing-relapsed-refractory-dlbcl-bispecific-antibody-2025a1000zir

No hay comentarios:

Publicar un comentario